{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:38:22Z","timestamp":1792071502456,"version":"4.4.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>Autism spectrum disorder (ASD) is a group of heterogeneous neurodevelopmental disorders that is characterized by core features in social communication impairment and restricted, repetitive sensory-motor behaviors. This study aimed to further investigate the utilization of fecal microbiota transplantation (FMT) in children with ASD, both with and without gastrointestinal (GI) symptoms, evaluate the effect of FMT and analyze the alterations in bacterial and fungal composition within the gut microbiota.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 38 children diagnosed with ASD participated in the study and underwent oral lyophilized FMT treatment. The dosage of the FMT treatment was determined based on a ratio of 1\u2005g of donor stool per 1\u2005kg of recipient body weight, with a frequency of once every 4 weeks for a total of 12 weeks. In addition, 30 healthy controls (HC) were included in the analysis. The clinical efficacy of FMT was evaluated, while the composition of fecal bacteria and fungi was determined using 16S rRNA and ITS gene sequencing methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Median age of the 38 children with ASD was 7 years. Among these children, 84.2% (32 of 38) were boys and 81.6% (31 of 38) exhibited GI symptoms, with indigestion, constipation and diarrhea being the most common symptoms. Sample collections and assessments were conducted at baseline (week 0), post-treatment (week 12) and follow-up (week 20). At the end of the follow-up phase after FMT treatment, the autism behavior checklist (ABC) scores decreased by 23% from baseline, and there was a 10% reduction in scores on the childhood autism rating scale (CARS), a 6% reduction in scores on the social responsiveness scale (SRS) and a 10% reduction in scores on the sleep disturbance scale for children (SDSC). In addition, short-term adverse events observed included vomiting and fever in 2 participants, which were self-limiting and resolved within 24\u2005h, and no long-term adverse events were observed. Although there was no significant difference in alpha and beta diversity in children with ASD before and after FMT therapy, the FMT treatment resulted in alterations in the relative abundances of various bacterial and fungal genera in the samples of ASD patients. Comparisons between children with ASD and healthy controls (HC) revealed statistically significant differences in microbial abundance before and after FMT.\n                      <jats:italic>Blautia<\/jats:italic>\n                      ,\n                      <jats:italic>Sellimonas<\/jats:italic>\n                      ,\n                      <jats:italic>Saccharomycopsis<\/jats:italic>\n                      and\n                      <jats:italic>Cystobasidium<\/jats:italic>\n                      were more abundant in children with ASD than in HC, while\n                      <jats:italic>Dorea<\/jats:italic>\n                      were less abundant. After FMT treatment, levels of\n                      <jats:italic>Blautia, Sellimonas<\/jats:italic>\n                      ,\n                      <jats:italic>Saccharomycopsis<\/jats:italic>\n                      and\n                      <jats:italic>Cystobasidium<\/jats:italic>\n                      decreased, while levels of\n                      <jats:italic>Dorea<\/jats:italic>\n                      increased. Moreover, the increased abundances of\n                      <jats:italic>Fusicatenibacter, Erysipelotrichaceae_UCG-003, Saccharomyces, Rhodotorula, Cutaneotrichosporon<\/jats:italic>\n                      and\n                      <jats:italic>Zygosaccharomyces<\/jats:italic>\n                      were negatively correlated with the scores of ASD core symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Oral lyophilized FMT could improve GI and ASD related symptoms, as well as sleep disturbances, and alter the gut bacterial and fungal microbiota composition in children with ASD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration<\/jats:title>\n                    <jats:p>\n                      Chinese Clinical Trial Registry, ChiCTR2200055943. Registered 28 January 2022,\n                      <jats:ext-link>www.chictr.org.cn<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2024.1369823","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T01:08:20Z","timestamp":1715216900000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Effects and microbiota changes following oral lyophilized fecal microbiota transplantation in children with autism spectrum disorder"],"prefix":"10.3389","volume":"12","author":[{"given":"Youran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","article-title":"Autism spectrum disorder","volume":"392","author":"Lord","year":"2018","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.2022.23661","article-title":"Autism spectrum disorder: a review","volume":"329","author":"Hirota","year":"2023","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1038\/s41380-022-01630-7","article-title":"Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries","volume":"27","author":"Solmi","year":"2022","journal-title":"Mol Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"103359","DOI":"10.1016\/j.ajp.2022.103359","article-title":"Global, regional, and national disease burden of autism spectrum disorder among children under 5 years from 1990 to 2019: an analysis for the global burden of disease 2019 study","volume":"79","author":"Kang","year":"2023","journal-title":"Asian J Psychiatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3390\/ijms24031819","article-title":"Autism spectrum disorder: neurodevelopmental risk factors, biological mechanism, and precision therapy","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/nu11030521","article-title":"Autism spectrum disorders and the gut microbiota","volume":"11","author":"Fattorusso","year":"2019","journal-title":"Nutrients"},{"key":"B7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/nu12030792","article-title":"Composition of gut microbiota in children with autism spectrum disorder: a systematic review and meta-analysis","volume":"12","author":"Iglesias-V\u00e1zquez","year":"2020","journal-title":"Nutrients"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.2147\/NDT.S382571","article-title":"Fecal microbiota transplantation in autism spectrum disorder","volume":"18","author":"Li","year":"2022","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jgg.2021.07.001","article-title":"Microbiota-gut-brain axis in autism spectrum disorder","volume":"48","author":"Yu","year":"2021","journal-title":"J Genet Genomics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/jama.2017.6466","article-title":"Fecal microbiota transplantation","volume":"318","author":"Gupta","year":"2017","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s12519-022-00655-w","article-title":"Fecal microbiota transplantation in childhood: past, present, and future","volume":"19","author":"Gu","year":"2023","journal-title":"World J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00248-020-01494-w","article-title":"Therapeutic effects of the in vitro cultured human gut microbiota as transplants on altering gut microbiota and improving symptoms associated with autism spectrum disorder","volume":"80","author":"Chen","year":"2020","journal-title":"Microb Ecol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"118497","DOI":"10.1016\/j.lfs.2020.118497","article-title":"The effect of fecal microbiota transplantation on autistic-like behaviors in Fmr1 KO mice","volume":"262","author":"Goo","year":"2020","journal-title":"Life Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/brainsci11081038","article-title":"Fecal transplant and bifidobacterium treatments modulate gut clostridium bacteria and rescue social impairment and hippocampal BDNF expression in a rodent model of autism","volume":"11","author":"Abuaish","year":"2021","journal-title":"Brain Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s12031-021-01959-8","article-title":"The efficacy of fecal transplantation and bifidobacterium supplementation in ameliorating propionic acid-induced behavioral and biochemical autistic features in juvenile male rats","volume":"72","author":"Abuaish","year":"2022","journal-title":"J Mol Neurosci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/nu14071471","article-title":"Gastrointestinal symptoms in autism spectrum disorder: a systematic review","volume":"14","author":"Leader","year":"2022","journal-title":"Nutrients"},{"key":"B17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/jamapsychiatry.2014.3034","article-title":"Association of maternal report of infant and toddler gastrointestinal symptoms with autism: evidence from a prospective birth cohort","volume":"72","author":"Bresnahan","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s10803-013-1973-x","article-title":"Gastrointestinal problems in children with autism, developmental delays or typical development","volume":"44","author":"Chaidez","year":"2014","journal-title":"J Autism Dev Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","article-title":"Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study","volume":"5","author":"Kang","year":"2017","journal-title":"Microbiome"},{"key":"B20","doi-asserted-by":"publisher","first-page":"759435","DOI":"10.3389\/fcimb.2021.759435","article-title":"Fecal microbiota transplantation relieves gastrointestinal and autism symptoms by improving the gut microbiota in an open-label study","volume":"11","author":"Li","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1136\/gutjnl-2019-319548","article-title":"International consensus conference on stool banking for faecal microbiota transplantation in clinical practice","volume":"68","author":"Cammarota","year":"2019","journal-title":"Gut"},{"key":"B22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13238-019-00684-8","article-title":"Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening","volume":"11","author":"Zhang","year":"2020","journal-title":"Protein Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3389\/fmicb.2018.02622","article-title":"Clinical efficacy and microbiome changes following fecal microbiota transplantation in children with recurrent clostridium difficile infection","volume":"9","author":"Li","year":"2018","journal-title":"Front Microbiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/1751-2980.13135","article-title":"Fecal microbiota transplantation relieves abdominal bloating in children with functional gastrointestinal disorders via modulating the gut microbiome and metabolome","volume":"23","author":"Wang","year":"2022","journal-title":"J Dig Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3760\/cma.j.cn.441530-20200420-00231","article-title":"Chinese experts consensus on standardized methodology and clinical application of fecal microbiota transplantation","volume":"23","year":"2020","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","article-title":"FLASH: fast length adjustment of short reads to improve genome assemblies","volume":"27","author":"Mago\u010d","year":"2011","journal-title":"Bioinformatics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"Fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: high-resolution sample inference from illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"key":"B29","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1038\/s41598-019-42183-0","article-title":"Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota","volume":"9","author":"Kang","year":"2019","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1136\/gutjnl-2021-325115","article-title":"Deviated and early unsustainable stunted development of gut microbiota in children with autism spectrum disorder","volume":"71","author":"Lou","year":"2022","journal-title":"Gut"},{"key":"B32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41398-019-0389-6","article-title":"Altered composition and function of intestinal microbiota in autism spectrum disorders: a systematic review","volume":"9","author":"Liu","year":"2019","journal-title":"Transl Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/aur.2358","article-title":"Changes in the gut microbiota of children with autism spectrum disorder","volume":"13","author":"Zou","year":"2020","journal-title":"Autism Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1136\/gutjnl-2020-324015","article-title":"Underdevelopment of the gut microbiota and bacteria species as non-invasive markers of prediction in children with autism spectrum disorder","volume":"71","author":"Wan","year":"2022","journal-title":"Gut"},{"key":"B35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12887-019-1896-6","article-title":"Autism spectrum disorder is associated with gut microbiota disorder in children","volume":"19","author":"Sun","year":"2019","journal-title":"BMC Pediatr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"13981","DOI":"10.1038\/s41598-018-32219-2","article-title":"Analysis of gut microbiota profiles and microbe-disease associations in children with autism spectrum disorders in China","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jpsychires.2020.06.032","article-title":"Gut microbiota changes in patients with autism spectrum disorders","volume":"129","author":"Ding","year":"2020","journal-title":"J Psychiatr Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3389\/fmicb.2016.01227","article-title":"Age and gender affect the composition of fungal population of the human gastrointestinal tract","volume":"7","author":"Strati","year":"2016","journal-title":"Front Microbiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40168-017-0242-1","article-title":"New evidences on the altered gut microbiota in autism spectrum disorders","volume":"5","author":"Strati","year":"2017","journal-title":"Microbiome"},{"key":"B40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11046-016-0068-6","article-title":"Intestinal dysbiosis and yeast isolation in stool of subjects with autism spectrum disorders","volume":"182","author":"Iovene","year":"2017","journal-title":"Mycopathologia"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1369823\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T01:09:24Z","timestamp":1715216964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1369823\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":40,"alternative-id":["10.3389\/fped.2024.1369823"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1369823","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]},"article-number":"1369823"}}